Navigation Links
Hikma Expands its Global Injectables Business - Live Webcast
Date:10/29/2010

Hikma Expands its Global Injectables Business - Live Webcast -- LONDON, October 29, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Acquisitions, Mergers and Takeovers, New Products & Services Click to view news release full screen  

Hikma Expands its Global Injectables Business - Live Webcast

 

LONDON, October 29, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals, the multinational pharmaceutical group, announces that it has signed an agreement to acquire Baxter Healthcare Corporation's US generic injectables business for a cash consideration of $112 million.

There will be a live analyst and investor webcast outlining the event on http://www.cantos.com at 0930 BST. An on-demand replay of the webcast will also be available.

Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email amanda.alexander@cantos.com or phone +44-207-936-1352.


'/>"/>
SOURCE Hikma Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Hikma - Half Year Results Interviews With CEO and CFO
2. HIKMA - 2008 Preliminary Results Interview With CEO
3. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
4. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
5. Beta-Pro Expands Operations to Meet Demands for Human Cells in Hepatocyte Drug Discovery Market
6. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
7. Vital Therapies Expands SILVER Trial to Saudi Arabia
8. Launch of Two New Platforms for Microplate Analysis Expands Reader Portfolio and Ensures Molecular Devices Readers Meet all Combinations of Customer Needs
9. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
10. Advanced Life Sciences Expands Antibiotic Pipeline
11. London Genetics Expands its Senior Advisory Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 22, 2017 , ... Park Systems , a leader in Atomic Force ... SPIE attendees and Park customers on Feb. 27, 2017 from 12-2pm at ... Convention Center. The luncheon will feature a talk on Automated AFM for Small-Scale ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS ... precision treatments for neurodegenerative diseases, today announced it has issued a scientific white ... is one of a series of commentaries from ProMIS’s scientific team offering insight ...
(Date:2/22/2017)... DES MOINES, Iowa , Feb. 22, 2017 Origin ... an agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and ... of a key corn biotechnology product developed in China ... completion of global regulatory trials. ...
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017 /PRNewswire/ ... today expansion of its translational research program using ... establishment of laboratory facilities in San Diego.  The ... Diego BioLabs facility, a biotechnology incubator sponsored by ... In November 2016, the Company obtained ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):